| 前收市價 | 174.87 |
| 開市 | 174.87 |
| 買盤 | 210.00 |
| 賣出價 | 218.00 |
| 拍板 | 710.00 |
| 到期日 | 2025-12-19 |
| 今日波幅 | 174.87 - 174.87 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 22 |
Motley FoolThis Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
These stocks are trading at sky-high valuations which could make them vulnerable to sell-offs.
Investor's Business DailyS&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Eli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all trading in or near buy zones. Medical stocks are often viewed as defensive growth stocks, because their growth is insulated from economic swings due to the government or insurance covering most of the costs. Eli Lilly is in a buy zone while weight-loss drug rival and fellow IBD Leaderboard member Novo Nordisk is setting up.
ZacksTop Research Reports for Eli Lilly, T-Mobile & BHP
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), T-Mobile US, Inc. (TMUS) and BHP Group Limited (BHP).
